Stay Focused on SCHIP

Congress and the White House are poised for a showdown over reauthorization of the State Children's Health Insurance Program before the program expires on September 30, with both houses having passed legislation that the president has vowed to veto...

SCHIP Reauthorization: Views, insights, and implications

Please join us for a news conference on: SCHIP Reauthorization: Views, insights, and implications

Drug Safety or Drug Danger?

Two pieces of legislation dealing with prescription drugs are currently winding their way through Congress. The bills, however, are completely contradictory. One would create new controls for drug safety. The other would open the nation's supply chain...

Response to the AMA's call to ban retail health clinics

The American Medical Association's call to ban retail health clinics is disheartening ("AMA takes on retail clinics," June 25). The AMA claims that retail health clinics are unsafe. But the clinics follow protocols from the Mayo Clinic and other...

Is There a Role for Markets in Health Care?

The Galen Institute and the International Policy Network co-hosted an event on Thursday, June 14, on "Is There a Role for Markets in Health Care?" Is there a way to use the dynamic, global marketplace to advance common international goals of making health...

SCHIP Guidelines

Members of the Health Policy Consensus Group offer the following guidelines to policymakers for consideration during debate over reauthorization of the State Children's Health Insurance Program (SCHIP). We also offer a brief summary of our...

Customer Health Care

It's Friday evening and you suspect that your child might have strep throat or a worsening ear infection. Do you bundle him up and wait half the night in an emergency room? Or do you suffer through the weekend and hope that you can get an appointment with...

Customer Health Care